Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2017 second-quarter earnings
J&J Building Flag Summer

What you need to know about Johnson & Johnson’s 2017 second-quarter earnings

Check out this infographic breakdown of the company’s second-quarter 2017 performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Johnson & Johnson shared financial information this morning about its second-quarter performance in 2017.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

For more details about the company’s second-quarter 2017 results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic packed with key stats.

2017 Second Quarter Earnings

Johnson & Johnson’s 2017 2nd-Quarter Earnings

Read the earnings press release, which includes full financial data for the second quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson quarterly and full-year results here.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.